These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma. Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473 [TBL] [Abstract][Full Text] [Related]
24. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. Zeng MS; Li DJ; Liu QL; Song LB; Li MZ; Zhang RH; Yu XJ; Wang HM; Ernberg I; Zeng YX J Virol; 2005 Dec; 79(24):15323-30. PubMed ID: 16306603 [TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. Niedobitek G; Agathanggelou A; Nicholls JM Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600 [TBL] [Abstract][Full Text] [Related]
26. [Proliferation cycle changes of Epstein-Barr virus in nasopharyngeal carcinoma cell line CNE after infection]. He YW; Zeng J; Ou XL; Zhang G; Du J Ai Zheng; 2008 May; 27(5):455-9. PubMed ID: 18479592 [TBL] [Abstract][Full Text] [Related]
27. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma]. Zhang Y; Gao HY; Feng HX; Deng L; Huang MY; Hu B; Cheng G; Wu QL; Cui NJ; Shao JY Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):982-6. PubMed ID: 15312530 [TBL] [Abstract][Full Text] [Related]
28. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma. Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC). Liu MT; Yeh CY Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898 [TBL] [Abstract][Full Text] [Related]
30. [Expression of Epstein-Barr virus A73 gene in nasopharyngeal carcinoma tissues and its subcellular location]. Li A; Zhang XS; Wang HH; Jiang JH; Liu XQ; Liu QC; Zeng YX Ai Zheng; 2003 Jun; 22(6):597-601. PubMed ID: 12948408 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies. Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121 [TBL] [Abstract][Full Text] [Related]
32. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma]. Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192 [TBL] [Abstract][Full Text] [Related]
33. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Sugawara Y; Mizugaki Y; Uchida T; Torii T; Imai S; Makuuchi M; Takada K Virology; 1999 Apr; 256(2):196-202. PubMed ID: 10191184 [TBL] [Abstract][Full Text] [Related]
34. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma. Takimoto T; Umeda R Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937 [TBL] [Abstract][Full Text] [Related]
35. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais. Tiwawech D; Srivatanakul P; Karalak A; Ishida T J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201 [TBL] [Abstract][Full Text] [Related]
36. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Seto E; Ooka T; Middeldorp J; Takada K Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477 [TBL] [Abstract][Full Text] [Related]
37. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin. Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255 [TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases. Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. Seto E; Yang L; Middeldorp J; Sheen TS; Chen JY; Fukayama M; Eizuru Y; Ooka T; Takada K J Med Virol; 2005 May; 76(1):82-8. PubMed ID: 15778977 [TBL] [Abstract][Full Text] [Related]
40. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma. Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]